{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T20:42:00Z","timestamp":1782333720858,"version":"3.54.5"},"reference-count":62,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014573","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T11:26:02Z","timestamp":1704885962000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Oral killed cholera vaccines for preventing cholera"],"prefix":"10.1002","volume":"2024","author":[{"given":"KM","family":"Saif-Ur-Rahman","sequence":"additional","affiliation":[{"name":"Health Systems and Population Studies Division; icddr,b; Dhaka Bangladesh"},{"name":"College of Medicine, Nursing and Health Sciences; University of Galway; Galway Ireland"},{"name":"Evidence Synthesis Ireland and Cochrane Ireland; University of Galway; Galway Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razib","family":"Mamun","sequence":"additional","affiliation":[{"name":"Department of Public Health and Health Systems, Graduate School of Medicine; Nagoya University; Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md","family":"Hasan","sequence":"additional","affiliation":[{"name":"Department of Public Health and Informatics; Bangabandhu Sheikh Mujib Medical University; Dhaka Bangladesh"},{"name":"Department of Community Health Science, Max Rady College of Medicine; University of Manitoba; Manitoba Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E","family":"Meiring","sequence":"additional","affiliation":[{"name":"Division of Clinical Medicine, School of Medicine and Population Health; University of Sheffield; Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Arifuzzaman","family":"Khan","sequence":"additional","affiliation":[{"name":"School of Public Health, Faculty of Medicine; The University of Queensland; Brisbane Australia"},{"name":"Central Queensland Public Health Unit, Central Queensland Hospital and Health Service; Department of Health; Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD014573-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5-year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bhattacharya","year":"2013","journal-title":"Lancet Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD014573-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12879-018-2981-4","article-title":"Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trial","volume":"18","author":"Fong","year":"2018","journal-title":"BMC Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD014573-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"e1289","DOI":"10.1371\/journal.pntd.0001289","article-title":"Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial","volume":"5","author":"Sur","year":"2011","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"9702","key":"10.1002\/14651858.CD014573-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1694-702","DOI":"10.1016\/S0140-6736(09)61297-6","article-title":"Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial","volume":"374","author":"Sur","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD014573-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S1473-3099(20)30781-7.","article-title":"Effectiveness of a killed whole-cell oral cholera vaccine in Bangladesh: further follow-up of a cluster-randomised trial","volume":"21","author":"Ali","year":"2021","journal-title":"Lancet Infectious Diseases"},{"issue":"11","key":"10.1002\/14651858.CD014573-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.vaccine.2017.01.080","article-title":"Safety of the oral cholera vaccine in pregnancy: retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh","volume":"35","author":"Khan","year":"2017","journal-title":"Vaccine"},{"issue":"10001","key":"10.1002\/14651858.CD014573-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0140-6736(15)61140-0","article-title":"Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial","volume":"386","author":"Qadri","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD014573-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s12879-019-4006-3","article-title":"Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: evidence from a randomized placebo-controlled trial","volume":"19","author":"Khan","year":"2019","journal-title":"BMC Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD014573-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1473-3099(18)30108-7","article-title":"Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial","volume":"18","author":"Qadri","year":"2018","journal-title":"Lancet Infectious Diseases"},{"issue":"18","key":"10.1002\/14651858.CD014573-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1510330","article-title":"Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh","volume":"374","author":"Qadri","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"8932","key":"10.1002\/14651858.CD014573-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/s0140-6736(94)90755-2","article-title":"Protective efficacy of oral whole-cell\/recombinant-B-subunit cholera vaccine in Peruvian military recruits","volume":"344","author":"Sanchez","year":"1994","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD014573-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1086\/315462","article-title":"Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru","volume":"181","author":"Taylor","year":"2000","journal-title":"Journal of Infectious Diseases"},{"issue":"46","key":"10.1002\/14651858.CD014573-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"6360","DOI":"10.1016\/j.vaccine.2015.08.075","article-title":"A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines","volume":"33","author":"Baik","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1002\/14651858.CD014573-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.vaccine.2021.12.015","article-title":"A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh","volume":"40","author":"Chowdhury","year":"2022","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD014573-BIB0015|cit15","first-page":"417","article-title":"Field trial of oral cholera vaccines in Bangladesh","volume":"19","author":"Clemens","year":"1988","journal-title":"Southeast Asian Journal of Tropical Medicine and Public Health"},{"issue":"1","key":"10.1002\/14651858.CD014573-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/infdis\/158.1.60","article-title":"Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up","volume":"158","author":"Clemens","year":"1988","journal-title":"Journal of Infectious Diseases"},{"issue":"8499","key":"10.1002\/14651858.CD014573-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/s0140-6736(86)91944-6","article-title":"Field trial of oral cholera vaccines in Bangladesh","volume":"2","author":"Clemens","year":"1986","journal-title":"Lancet"},{"issue":"8599","key":"10.1002\/14651858.CD014573-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/s0140-6736(88)92189-7","article-title":"Impact of B subunit killed whole-cell and killed whole-cell-only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera","volume":"1","author":"Clemens","year":"1988","journal-title":"Lancet"},{"issue":"8684","key":"10.1002\/14651858.CD014573-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-o","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up","volume":"335","author":"Clemens","year":"1990","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD014573-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/infdis\/166.5.1029","article-title":"Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area","volume":"166","author":"Clemens","year":"1992","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD014573-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/0264-410x(95)00122-h","article-title":"Field trial of inactivated oral cholera vaccines in Bangladesh: results from 5 years of follow-up","volume":"14","author":"Van Loon","year":"1996","journal-title":"Vaccine"},{"issue":"7","key":"10.1002\/14651858.CD014573-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"e1743","DOI":"10.1371\/journal.pntd.0001743","article-title":"Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy","volume":"6","author":"Hashim","year":"2012","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD014573-BIB0023|cit23","first-page":"324-5","article-title":"Effect of a bivalent, killed, whole cell oral cholera vaccine on pregnancy outcome in Bangladesh","volume":"95","author":"Khan","year":"2016","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"6","key":"10.1002\/14651858.CD014573-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"e2323","DOI":"10.1371\/journal.pone.0002323","article-title":"A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India","volume":"3","author":"Mahalanabis","year":"2008","journal-title":"PLoS One"},{"issue":"32","key":"10.1002\/14651858.CD014573-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1016\/j.vaccine.2021.06.034","article-title":"Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia","volume":"39","author":"Mwaba","year":"2021","journal-title":"Vaccine"},{"issue":"29","key":"10.1002\/14651858.CD014573-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1016\/j.vaccine.2018.05.102","article-title":"A randomized, observer-blinded, equivalence trial comparing two variations of Euvichol\u00ae, a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines","volume":"36","author":"Russo","year":"2018","journal-title":"Vaccine"},{"issue":"4","key":"10.1002\/14651858.CD014573-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/00006454-200204000-00012","article-title":"Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants","volume":"21","author":"Savarino","year":"2002","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"9047","key":"10.1002\/14651858.CD014573-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/s0140-6736(96)06107-7","article-title":"Field trial of a locally produced, killed, oral cholera vaccine in Vietnam","volume":"349","author":"Trach","year":"1997","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD014573-BIB0029|cit29","first-page":"441","article-title":"Cholera vaccine: developmental strategies and problems","volume":"31","author":"Bhadra","year":"1994","journal-title":"Indian Journal of Biochemistry and Biophysics"},{"issue":"10","key":"10.1002\/14651858.CD014573-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","article-title":"Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis","volume":"17","author":"Bi","year":"2017","journal-title":"Lancet Infectious Diseases"},{"issue":"32","key":"10.1002\/14651858.CD014573-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1016\/j.vaccine.2021.06.069","article-title":"A phase I\/II study to evaluate safety, tolerability and immunogenicity of Hillchol\u00ae, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh","volume":"39","author":"Chowdhury","year":"2021","journal-title":"Vaccine"},{"issue":"4","key":"10.1002\/14651858.CD014573-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/infdis\/159.4.770","article-title":"ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy","volume":"159","author":"Clemens","year":"1989","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD014573-BIB0033|cit33","volume-title":"Medical Microbiology","volume":"24","author":"Finkelstein","year":"1996"},{"issue":"15","key":"10.1002\/14651858.CD014573-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.vaccine.2005.10.014","article-title":"A review of vaccine research and development: human enteric infections","volume":"24","author":"Girard","year":"2006","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD014573-BIB0035|cit35","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"issue":"11","key":"10.1002\/14651858.CD014573-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1128\/IAI.73.11.7422-7427.2005","article-title":"Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity","volume":"73","author":"Harris","year":"2005","journal-title":"Infection and Immunity"},{"issue":"2","key":"10.1002\/14651858.CD014573-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4269\/ajtmh.16-0440","article-title":"Cholera and ABO blood group: understanding an ancient association","volume":"95","author":"Harris","year":"2016","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD014573-BIB0038|cit38","volume-title":"Control of Communicable Diseases Manual","author":"Heyman","year":"2008"},{"key":"10.1002\/14651858.CD014573-BIB0039|cit39","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"6","key":"10.1002\/14651858.CD014573-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(06)70494-7","article-title":"Oral cholera vaccines: use in clinical practice","volume":"6","author":"Hill","year":"2006","journal-title":"Lancet Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD014573-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.imlet.2004.11.009","article-title":"Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA","volume":"97","author":"Holmgren","year":"2005","journal-title":"Immunology Letters"},{"issue":"5","key":"10.1002\/14651858.CD014573-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"e0003809","DOI":"10.1371\/journal.pntd.0003809","article-title":"An open label non-inferiority trial assessing vibriocidal response of a killed bivalent oral cholera vaccine regimen following a five year interval in Kolkata, India","volume":"9","author":"Kanungo","year":"2015","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"5","key":"10.1002\/14651858.CD014573-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/2051013614537819","article-title":"Killed oral cholera vaccines: history, development and implementation challenges","volume":"2","author":"Lopez","year":"2014","journal-title":"Therapeutic Advances in Vaccines"},{"issue":"12","key":"10.1002\/14651858.CD014573-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1093\/cid\/cix1039","article-title":"Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and metaanalysis","volume":"66","author":"Lopez","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014573-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"A148","DOI":"10.1016\/j.vaccine.2019.07.029","article-title":"Preventing cholera in India: synthesizing evidences through a systematic review for policy discussion on the use of oral cholera vaccine","volume":"38","author":"Panda","year":"2020","journal-title":"Vaccine"},{"issue":"8","key":"10.1002\/14651858.CD014573-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1128\/CVI.00123-10","article-title":"A large study on immunological response to a whole-cell killed oral cholera vaccine reveals that there are significant geographical differences in response and that O blood group individuals do not elicit a higher response","volume":"17","author":"Ramamurthy","year":"2010","journal-title":"Clinical and Vaccine Immunology"},{"key":"10.1002\/14651858.CD014573-BIB0047|cit47","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2023"},{"issue":"9404","key":"10.1002\/14651858.CD014573-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0140-6736(03)15328-7","article-title":"Cholera","volume":"363","author":"Sack","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD014573-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1017\/S1049023X17007166","article-title":"A quantitative systematic review and meta-analysis of the effectiveness of oral cholera vaccine as a reactive measure in cholera outbreaks","volume":"33","author":"Schwerdtle","year":"2018","journal-title":"Prehospital and Disaster Medicine"},{"key":"10.1002\/14651858.CD014573-BIB0050|cit50","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"issue":"12","key":"10.1002\/14651858.CD014573-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/jphp.13344","article-title":"A comprehensive review of therapeutic approaches available for the treatment of cholera","volume":"72","author":"Sousa","year":"2020","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"9068","key":"10.1002\/14651858.CD014573-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0140-6736(97)04486-3","article-title":"Cholera","volume":"349","author":"S\u00e1nchez","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD014573-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1080\/21645515.2017.1392422","article-title":"Global economic evaluation of oral cholera vaccine: a systematic review","volume":"14","author":"Teoh","year":"2018","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"31","key":"10.1002\/14651858.CD014573-BIB0054|cit54","first-page":"297","article-title":"Cholera 2005","volume":"81","author":"World Health Organization (WHO)","year":"2006","journal-title":"Weekly Epidemiological Record"},{"issue":"14","key":"10.1002\/14651858.CD014573-BIB0055|cit55","first-page":"109","article-title":"Outbreak news: cholera, Zimbabwe - update","volume":"84","author":"World Health Organization (WHO)","year":"2009","journal-title":"Weekly Epidemiological Record"},{"issue":"49","key":"10.1002\/14651858.CD014573-BIB0056|cit56","first-page":"489","article-title":"Outbreak news: cholera, Haiti \u2013 update","volume":"85","author":"World Health Organization (WHO)","year":"2010","journal-title":"Weekly Epidemiological Record"},{"issue":"34","key":"10.1002\/14651858.CD014573-BIB0057|cit57","first-page":"477","article-title":"Cholera vaccines: WHO position paper \u2013 August 2017","volume":"92","author":"World Health Organization (WHO)","year":"2017","journal-title":"Weekly Epidemiological Record"},{"key":"10.1002\/14651858.CD014573-BIB0058|cit58","unstructured":"World Health Organization (WHO) Cholera who.int\/news-room\/fact-sheets\/detail\/cholera"},{"key":"10.1002\/14651858.CD014573-BIB0059|cit59","unstructured":"World Health Organization (WHO) Cholera \u2013 Global situation who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON437"},{"issue":"2","key":"10.1002\/14651858.CD014573-BIB0060|cit60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000974","article-title":"Vaccines for preventing cholera","author":"Graves","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD014573-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000974.pub2","article-title":"Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected)","author":"Graves","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD014573-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008603.pub2","article-title":"Oral vaccines for preventing cholera","author":"Sinclair","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T16:47:18Z","timestamp":1731343638000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014573"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014573","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,10]]}}}